Endo International plc
USD0.37
+0.01 (+1.99%)
CEO
Blaise Coleman
IPO Date
2014-03-03
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$0.39
Prev. Close
$0.37
Day Low
$0.37
Day High
$0.40
Volume
20.61M
| 26,805 |
| $0.00 |
| 31 Mar 2022 | Bradley Mark T. | EVP, Chief Financial Officer | M-Exempt | Acquired | 10,735 | $0.00 |
| 31 Mar 2022 | Bradley Mark T. | EVP, Chief Financial Officer | F-InKind | Disposed | 3,057 | $2.52 |
| 31 Mar 2022 | Bradley Mark T. | EVP, Chief Financial Officer | F-InKind | Disposed | 2,544 | $2.52 |
| 31 Mar 2022 | Coleman Blaise | President, CEO | M-Exempt | Disposed | 89,663 | $0.00 |
| 31 Mar 2022 | Coleman Blaise | President, CEO | F-InKind | Disposed | 10,137 | $2.52 |
| 31 Mar 2022 | Maletta Matthew Joseph | EVP, CLO & Company Secretary | M-Exempt | Acquired | 34,414 | $0.00 |
| 31 Mar 2022 | Maletta Matthew Joseph | EVP, CLO & Company Secretary | F-InKind | Disposed | 10,179 | $2.52 |
| 31 Mar 2022 | Barry Patrick A | EVP & Pres,Global Comm Ops | M-Exempt | Disposed | 42,341 | $0.00 |